The revenue for Povorcitinib is expected to reach an annual total of $91 mn by 2035 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...
Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH ...
INCY's phase III study, evaluating retifanlimab in combination with platinum-based chemotherapy for the treatment of metastatic non-small cell lung cancer, meets primary and secondary endpoints.
I had both Shingrix shots about five years ago. I take hydroxyurea for polycythemia vera (PV). Around Aug. 1, I noticed some spots on my forearm that appeared to be a spider bite. I went to my ...